Bahl & Gaynor Inc Petmed Express Inc Transaction History

Bahl & Gaynor Inc

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 08, 2022	BUY	$19.9 - $26.13 $445,063 - $584,397	22,365 Added 24.44%	113,861 $2.27 Million
Q1 2022 May 12, 2022	SELL	$23.62 - $29.18 $1.29 Million - $1.6 Million	-54,790 Reduced 37.45%	91,496 $2.36 Million
Q4 2021 Feb 10, 2022	BUY	$25.26 - $32.0 $38,369 - $48,608	1,519 Added 1.05%	146,286 $3.7 Million
Q3 2021 Nov 15, 2021	SELL	$26.5 - $34.0 $8,321 - $10,676	-314 Reduced 0.22%	144,767 $3.89 Million
Q2 2021 Aug 06, 2021	BUY	$27.73 - $46.06 $1.62 Million - $2.7 Million	58,546 Added 67.66%	145,081 $4.62 Million
Q1 2021 May 11, 2021	SELL	$29.77 - $51.8 $786,523 - $1.37 Million	-26,420 Reduced 23.39%	86,535 $3.04 Million
Q4 2020 Feb 02, 2021	SELL	$28.96 - $33.77 $2,780 - $3,241	-96 Reduced 0.08%	112,955 $3.62 Million
Q3 2020 Nov 12, 2020	BUY	$29.0 - $41.83 $1.3 Million - $1.88 Million	44,977 Added 66.07%	113,051 $3.57 Million
Q2 2020 Aug 13, 2020	BUY	$27.94 - $40.96 $938,336 - $1.38 Million	33,584 Added 97.37%	68,074 $2.43 Million
Q2 2017 Aug 10, 2017	BUY	N/A	34,490	34,490 $796,000

102

9.52M

39.6K

137K

Ticker PETS
Exchange NASDAQ
Sector Healthcare
Industry Pharmaceutical Retailers
Shares Outstandng 21,013,800
Market Cap $111M
Description
PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint c...

Get notified when there are updates to the investment portfolio of Bahl & Gaynor Inc, based on Form 13F filings with the SEC.

Stay updated on Bahl & Gaynor Inc with notifications on news.